|
|
Evotec AG - Comparative Business Analysis Snapshot
Business Description
Evotec AG. The Group's principal activities are discovering and developing of new drugs. The Group operates through two segments: Discovery and development services and Discovery Programs Division. The Group's discovery and development services segment provides screening, assay development, chemical compound optimisation and production and disease targets. The discovery programs division focuses on internal discovery programs. The Group operates in Europe, USA and Rest of the World.
Competitor Analysis
This analysis compares Evotec AG with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
